相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: a randomized controlled noninferiority trial
Veronica F. Quinn et al.
GENETICS IN MEDICINE (2017)
Identifying Needs: a Qualitative Study of women's Experiences Regarding Rapid Genetic Testing for Hereditary Breast and Ovarian Cancer in the DNA BONus Study
Mirjam Tonheim Augestad et al.
JOURNAL OF GENETIC COUNSELING (2017)
Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer
Angela George et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics
Maira Kentwell et al.
GYNECOLOGIC ONCOLOGY (2017)
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Karoline B. Kuchenbaecker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Universal BRCA1/BRCA2 Testing for Ovarian Cancer Patients is Welcomed, but with Care: How Women and Staff Contextualize Experiences of Expanded Access
Hannah Shipman et al.
JOURNAL OF GENETIC COUNSELING (2017)
Rapid genetic counseling and testing in newly diagnosed breast cancer: Patients' and health professionals' attitudes, experiences, and evaluation of effects on treatment decision making
Marijke R. Wevers et al.
JOURNAL OF SURGICAL ONCOLOGY (2017)
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
Mark Robson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Baseline clinical predictors of antitumor response to the PARP inhibitor olaparib in germline BRCA1/2 mutated patients with advanced ovarian cancer
Saeed Rafii et al.
ONCOTARGET (2017)
BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study
Hildegunn Hoberg-Vetti et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2016)
Does rapid genetic counseling and testing in newly diagnosed breast cancer patients cause additional psychosocial distress? results from a randomized clinical trial
Marijke R. Wevers et al.
GENETICS IN MEDICINE (2016)
Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast Cancer
Akiko Chiba et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
When knowledge of a heritable gene mutation comes out of the blue: treatment-focused genetic testing in women newly diagnosed with breast cancer
B. Meiser et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2016)
Therapeutic appropriation: a new concept in the ethics of clinical research
Rosalind McDougall et al.
JOURNAL OF MEDICAL ETHICS (2016)
Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study
M. R. Wevers et al.
FAMILIAL CANCER (2015)
Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105
Melinda L. Telli et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Development of cancer genetic services in the UK: A national consultation
Ingrid Slade et al.
GENOME MEDICINE (2015)
Germline Mutation in BRCA1 or BRCA2 and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer
Francisco J. Candido-dos-Reis et al.
CLINICAL CANCER RESEARCH (2015)
Mainstreaming genetic testing of cancer predisposition genes
Nazneen Rahman
CLINICAL MEDICINE (2014)
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
Jonathan Ledermann et al.
LANCET ONCOLOGY (2014)
The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services
D. Gareth R. Evans et al.
BREAST CANCER RESEARCH (2014)
Communication and Information Needs of Women Diagnosed With Ovarian Cancer Regarding Treatment-Focused Genetic Testing
Margaret Gleeson et al.
ONCOLOGY NURSING FORUM (2013)
There is no decision to make: Experiences and attitudes toward treatment-focused genetic testing among women diagnosed with ovarian cancer
B. Meiser et al.
GYNECOLOGIC ONCOLOGY (2012)
BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation-Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
Kathryn Alsop et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
Jonathan Ledermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Breast cancer genetic counseling after diagnosis but before treatment: A pilot study on treatment consequences and psychological impact
Marijke R. Wevers et al.
PATIENT EDUCATION AND COUNSELING (2012)
Are we being overly cautious? A qualitative inquiry into the experiences and perceptions of treatment-focused germline BRCA genetic testing amongst women recently diagnosed with breast cancer
E. Zilliacus et al.
SUPPORTIVE CARE IN CANCER (2012)
Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer
Shiyu Zhang et al.
GYNECOLOGIC ONCOLOGY (2011)
Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval
Peter C. Fong et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The role of BRCA mutation testing in determining breast cancer therapy
Alison H. Trainer et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
The Effect of BRCA Gene Testing on Family Relationships: A Thematic Analysis of Qualitative Interviews
Heather A. Douglas et al.
JOURNAL OF GENETIC COUNSELING (2009)
The elephant in the living room: or extending the conversation about the politics of evidence
Norman K. Denzin
QUALITATIVE RESEARCH (2009)
BRCAness Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated With BRCA1 and BRCA2 Mutations
David S. P. Tan et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Experiences of Genetic Counseling for BRCA1/2 Among Recently Diagnosed Breast Cancer Patients: A Qualitative Inquiry
Susan T. Vadaparampil et al.
JOURNAL OF PSYCHOSOCIAL ONCOLOGY (2008)
Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda
Bettina Meiser et al.
BREAST CANCER RESEARCH (2008)
On doing 'being ordinary': women's accounts of BRCA testing and maternal responsibility
Emma Rowley
NEW GENETICS AND SOCIETY (2007)
Qualitative data analysis for health services research: Developing taxonomy, themes, and theory
Elizabeth H. Bradley et al.
HEALTH SERVICES RESEARCH (2007)
Short term psychological distress in patients actively approached for genetic counselling after diagnosis of breast cancer
Kathryn J. Schlich-Bakker et al.
EUROPEAN JOURNAL OF CANCER (2006)
Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40
A Ardern-Jones et al.
EUROPEAN JOURNAL OF CANCER CARE (2005)
Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients
MD Schwartz et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Psychological impact of genetic counseling for familial cancer: A systematic review and meta-analysis
D Braithwaite et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Accommodating risk:: Responses to BRCA1/2 genetic testing of women who have had cancer
N Hallowell et al.
SOCIAL SCIENCE & MEDICINE (2004)
Balancing autonomy and responsibility: the ethics of generating and disclosing genetic information
N Hallowell et al.
JOURNAL OF MEDICAL ETHICS (2003)
Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis
JN Weitzel et al.
ARCHIVES OF SURGERY (2003)
Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status
BG Haffty et al.
LANCET (2002)
Experiences of genetic risk: Disclosure and the gendering of responsibility
L d'Agincourt-Canning
BIOETHICS (2001)
分享论文
